Global pharmaceutical giant GlaxoSmithKline has invested $11m in expanding its Sri Lankan operations.
The investment will be welcomed by the government and its struggling economy.
Sri Lanka is facing difficulties in financing the upkeep of its military, proportionally one of the largest in the world.
A significant part of its national budget is dedicated to the defence ministry, headed by war crimes accused Gothabaya Rajapakse.
In a media statement, T. S. Dayanand, Managing Director of GSK Consumer Healthcare said, “Over the years, we have consistently invested in the Sri Lankan business. This new investment will enable us to bring more new products to our consumers. It will also help us localise more of our products and reduce dependence on imports.” reported The Sunday Times.
Every little kills... in Sri Lanka (12 Dec 2012)
Boycott, divestments and sanctions call against Sri Lanka (07 Sep 2012)
We need your support
Sri Lanka is one of the most dangerous places in the world to be a journalist. Tamil journalists are particularly at threat, with at least 41 media workers known to have been killed by the Sri Lankan state or its paramilitaries during and after the armed conflict.
Despite the risks, our team on the ground remain committed to providing detailed and accurate reporting of developments in the Tamil homeland, across the island and around the world, as well as providing expert analysis and insight from the Tamil point of view
We need your support in keeping our journalism going. Support our work today.
For more ways to donate visit https://donate.tamilguardian.com.
